Form 8.5 (EPT/RI) - Spire Healthcare Group plc

Summary by AI BETAClose X

An exempt principal trader acting as corporate broker disclosed purchases of 88,156 and sales of 50,081 Spire 1p ordinary shares on 11 November 2026 at prices between £2.4750 and £2.4800, yielding a net outright purchase of 38,075 shares; cash-settled equity swap transactions referenced 65,462 shares across decreases and increases in long/short positions at prices between £2.4748 and £2.4800, with no indemnities or related arrangements reported.

Disclaimer*

UK 100

Latest directors dealings